(Q40917088)

24 September 2017

1 reference

title

Unwanted pregnancies: understanding contraceptive use and benefits in adolescents and older women (English)

1 reference

24 September 2017

1 reference

1 reference

P J Sulak

1

1 reference

24 September 2017

A F Haney

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 1993

1 reference

American Journal of Obstetrics and Gynecology

24 September 2017

published in

1 reference

24 September 2017

volume

168

1 reference

24 September 2017

issue

6 Pt 2

1 reference

24 September 2017

page(s)

2042-2048

1 reference

The sexual and reproductive behavior of American women, 1982-1988.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Pelvic inflammatory disease and its sequelae in adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Effect of oral contraceptives on sebum excretion rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Elevated Free Testosterone Levels in Women With Acne

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Assessing risk for pelvic inflammatory disease and its sequelae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral contraceptive use in older women and fatal myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral contraceptives and death from myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral contraceptives and myocardial infarction in young women: a further report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Myocardial infarction in young women with special reference to oral contraceptive practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Mortality among women participating in the Oxford/Family Planning Association contraceptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral contraceptives and nonfatal myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral-contraceptive use in relation to myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Risk of Myocardial Infarction in Relation to Current and Discontinued Use of Oral Contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Coagulation effects of oral contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Oral contraceptive use and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

Contraception and the etiology of pelvic inflammatory disease: new perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

An epidemiologic study of young women with dysmenorrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Acute adolescent menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990947-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(12)90947-3

1 reference

24 September 2017

1 reference